News & Updates
Filter by Specialty:
Internet searchers could give real-time clues to population depression, anxiety burden
Internet searches related to depression or anxiety appear to be correlated with the population-wide burden of these mental health conditions, reports a recent US study.
Internet searchers could give real-time clues to population depression, anxiety burden
11 Jun 2022
OKINADA: TNF inhibition disappoints in knee osteoarthritis
Short-term tumour necrosis factor (TNF) inhibition with adalimumab falls short of producing improvements in patients with radiographic knee osteoarthritis, according to the proof-of-concept OKINADA trial presented at this year’s European Alliance of Associations for Rheumatology (EULAR) Congress.
OKINADA: TNF inhibition disappoints in knee osteoarthritis
10 Jun 2022
ARIC: Uncontrolled diabetes ups risk of heart failure progression in older adults
Uncontrolled diabetes among older adults with preclinical heart failure (HF) stages appears to increase the risk of HF progression, suggests a study.
ARIC: Uncontrolled diabetes ups risk of heart failure progression in older adults
10 Jun 2022
Patients with IGT show poor response to lifestyle changes
A study of Thai patients with impaired glucose tolerance (IGT) has found only a slight reduction in weight among its participants, highlighting the need for more intensive efforts with structured lifestyle programs to prevent diabetes.
Patients with IGT show poor response to lifestyle changes
10 Jun 2022
Obefazimod 50 mg for rheumatoid arthritis delivers in phase II trial
The investigational drug ABX464, also known as obefazimod, helps reduce disease activity in patients with rheumatoid arthritis (RA), according to the results of a phase II trial. The 50-mg dose is well tolerated, while the higher dose is associated with mild-to-moderate adverse effects resulting in treatment discontinuation.